Publicacións nas que colabora con Juan Jesús Gómez-Reino Carnota (21)

2022

  1. Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review

    Seminars in Arthritis and Rheumatism, Vol. 52

2018

  1. Correction to: Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology (Rheumatology International, (2018), 38, 3, (467-472), 10.1007/s00296-018-3930-7)

    Rheumatology International

  2. Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology

    Rheumatology International, Vol. 38, Núm. 3, pp. 467-472

2015

  1. High sodium intake is associated with self-reported rheumatoid arthritis: A cross sectional and case control analysis within the SUN cohort

    Medicine (United States), Vol. 94, Núm. 37

  2. Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: A systematic review and meta-analysis

    Arthritis and Rheumatology, Vol. 67, Núm. 1, pp. 117-127

  3. Predictors of response to TNF antagonists

    Current Pharmaceutical Design, Vol. 21, Núm. 2, pp. 221-232

  4. Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: Systematic review and meta-analysis

    RMD Open, Vol. 1, Núm. 1

2014

  1. Facteur rhumatoïde et réponse aux anti-TNF dans la polyarthrite rhumatoïde: revue systématique et méta-analyse d'études observationnelles

    Revue du Rhumatisme (Edition Francaise), Vol. 81, Núm. 1, pp. 58-68

  2. Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: Systematic review and meta-analysis

    Rheumatology (United Kingdom), Vol. 53, Núm. 5, pp. 834-838

  3. Observational study of optimization of biologic therapies in rheumatoid arthritis: A single-centre experience

    Rheumatology International, Vol. 34, Núm. 8, pp. 1059-1063

  4. Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

    Joint Bone Spine, Vol. 81, Núm. 1, pp. 41-50

  5. Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: A systematic review and meta-analysis of randomized controlled trials and long-term extension studies

    Rheumatology (United Kingdom), Vol. 53, Núm. 10, pp. 1872-1885

  6. Safety profile of protein kinase inhibitors in rheumatoid arthritis: Systematic review and meta-analysis

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 5, pp. 871-882

2013

  1. Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated inflammatory conditions: Systematic review and meta-analysis

    JAMA Internal Medicine, Vol. 173, Núm. 15, pp. 1416-1428

  2. Le facteur rhumatoïde ne semble pas prédire la réponse aux anti-TNF α dans la polyarthrite rhumatoïde: expérience de trois centres

    Revue du Rhumatisme (Edition Francaise)

  3. Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis

    Seminars in Arthritis and Rheumatism, Vol. 43, Núm. 1, pp. 9-17

  4. Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience

    Joint Bone Spine

  5. The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials

    International Journal of Clinical Rheumatology, Vol. 8, Núm. 3, pp. 315-326

2012

  1. Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

    Seminars in Arthritis and Rheumatism, Vol. 42, Núm. 1, pp. 89-103

2011

  1. The risk of tuberculosis in patients treated with TNF antagonists

    Expert Review of Clinical Immunology, Vol. 7, Núm. 3, pp. 329-340